RESUMO
The peroxisome proliferator-activated receptors (PPARs) are transcriptional regulators of glucose, lipid, and cholesterol metabolism. We report the x-ray crystal structure of the ligand binding domain of PPAR alpha (NR1C1) as a complex with the agonist ligand GW409544 and a coactivator motif from the steroid receptor coactivator 1. Through comparison of the crystal structures of the ligand binding domains of the three human PPARs, we have identified molecular determinants of subtype selectivity. A single amino acid, which is tyrosine in PPAR alpha and histidine in PPAR gamma, imparts subtype selectivity for both thiazolidinedione and nonthiazolidinedione ligands. The availability of high-resolution cocrystal structures of the three PPAR subtypes will aid the design of drugs for the treatments of metabolic and cardiovascular diseases.
Assuntos
Oxazóis/química , Receptores Citoplasmáticos e Nucleares/química , Fatores de Transcrição/química , Tirosina/análogos & derivados , Tirosina/química , Sequência de Aminoácidos , Sítios de Ligação , Cristalografia por Raios X , Humanos , Ligantes , Modelos Moleculares , Dados de Sequência Molecular , Estrutura Molecular , Estrutura Terciária de Proteína , Receptores Citoplasmáticos e Nucleares/agonistas , Fatores de Transcrição/agonistasRESUMO
BACKGROUND: The availability of complete genome sequences enables all the members of a gene family to be identified without limitations imposed by temporal, spatial or quantitative aspects of mRNA expression. Using the nearly completed human genome sequence, we combined in silico and experimental approaches to define the complete human nuclear receptor (NR) set. This information was used to carry out a comparative genomic study of the NR superfamily. RESULTS: Our analysis of the human genome identified two novel NR sequences. Both these contained stop codons within the coding regions, indicating that both are pseudogenes. One (HNF4 gamma-related) contained no introns and expressed no detectable mRNA, whereas the other (FXR-related) produced mRNA at relatively high levels in testis. If translated, the latter is predicted to encode a short, non-functional protein. Our analysis indicates that there are fewer than 50 functional human NRs, dramatically fewer than in Caenorhabditis elegans and about twice as many as in Drosophila. Using the complete human NR set we made comparisons with the NR sets of C. elegans and Drosophila. Searches for the >200 NRs unique to C. elegans revealed no human homologs. The comparative analysis also revealed a Drosophila member of NR subfamily NR3, confirming an ancient metazoan origin for this subfamily. CONCLUSIONS: This work provides the basis for new insights into the evolution and functional relationships of NR superfamily members.
Assuntos
Caenorhabditis elegans/genética , Drosophila melanogaster/genética , Evolução Molecular , Genoma , Receptores Citoplasmáticos e Nucleares/genética , Sequência de Aminoácidos , Animais , Proteínas de Caenorhabditis elegans/genética , Biologia Computacional , Bases de Dados Genéticas , Proteínas de Drosophila/genética , Genes de Helmintos/genética , Genes de Insetos/genética , Genômica , Humanos , Íntrons/genética , Dados de Sequência Molecular , Filogenia , Pseudogenes/genética , RNA Mensageiro/análise , RNA Mensageiro/genética , Alinhamento de SequênciaRESUMO
Cytochromes P450 (P450s) are involved in the oxidative metabolism of a plethora of structurally unrelated compounds, including therapeutic drugs. Two orphan members of the nuclear receptor superfamily, the pregnane X receptor (PXR; NR1I2) and constitutive androstane receptor (CAR; NR1I3) have been implicated in this phenomenon. In the present study, we examined the transcriptional regulation of the human CYP2B6 gene. In primary cultures of human hepatocytes, CYP2B6 was highly inducible by a number of compounds known to be human PXR ligands, including rifampicin and hyperforin. PXR was shown to be capable of activating the phenobarbital-responsive enhancer module (PBREM) region of the CYP2B6 gene, a 51-base-pair enhancer element that mediates induction of CYP2B6 expression by CAR. The two nuclear receptor-binding motifs within the PBREM effectively bound PXR as a heterodimer with the 9-cis retinoic acid receptor alpha (NR2B1). Taken together, these observations demonstrate that the CYP2B6 gene is directly regulated by PXR and further establish this receptor as a key regulator of drug-metabolizing P450s.
Assuntos
Hidrocarboneto de Aril Hidroxilases , Sistema Enzimático do Citocromo P-450/genética , Regulação Enzimológica da Expressão Gênica , Hepatócitos/enzimologia , Oxirredutases N-Desmetilantes/genética , Receptores Citoplasmáticos e Nucleares/fisiologia , Receptores de Esteroides/fisiologia , Motivos de Aminoácidos , Núcleo Celular/fisiologia , Células Cultivadas , Receptor Constitutivo de Androstano , Citocromo P-450 CYP2B6 , Sistema Enzimático do Citocromo P-450/biossíntese , Dimerização , Indução Enzimática , Humanos , Oxirredutases N-Desmetilantes/biossíntese , Receptor de Pregnano X , RNA Mensageiro/biossíntese , RNA Mensageiro/efeitos dos fármacos , Receptores Citoplasmáticos e Nucleares/química , Receptores Citoplasmáticos e Nucleares/genética , Receptores Citoplasmáticos e Nucleares/metabolismo , Receptores do Ácido Retinoico/genética , Receptores do Ácido Retinoico/metabolismo , Receptores de Esteroides/química , Receptores de Esteroides/genética , Receptores de Esteroides/metabolismo , Receptores X de Retinoides , Fatores de Transcrição/genética , Fatores de Transcrição/metabolismoRESUMO
A cell-free assay was developed for the orphan nuclear receptor LXRalpha that measures the ligand-dependent recruitment of a peptide from the steroid receptor coactivator 1 (SRC1) to the nuclear receptor. Using this ligand-sensing assay (LiSA), the structural requirements for activation of the receptor by oxysterols and related compounds were studied. The minimal pharmacophore for receptor activation was shown to be a sterol with a hydrogen bond acceptor at C24. 24(S),25-Epoxycholesterol (1), which meets this criterion, is among the most efficacious of the oxysterols and is an attractive candidate as the LXRalpha natural hormone. Cholenic acid dimethylamide (14) showed increased efficacy compared to 1, whereas the unnatural oxysterol 22(S)-hydroxycholesterol (4) was shown to be an antagonist of 1 in the LiSA. The structural requirements for SRC1 recruitment in the LiSA correlated with the transcriptional activity of compounds in a cell-based reporter assay employing LXRalpha-GAL4 chimeric receptors. Site-directed mutagenesis identified Trp(443) as an amino acid critical for activation of LXRalpha by oxysterol ligands. This information was combined with the structure-activity relationship developed from the LiSA to develop a 3D homology model of LXRalpha. This model may aid the design of synthetic drugs targeted at this transcriptional regulator of cholesterol homeostasis.
Assuntos
Colesterol/análogos & derivados , Receptores Citoplasmáticos e Nucleares/agonistas , Receptores de Esteroides/agonistas , Esteróis/farmacologia , Sequência de Aminoácidos , Animais , Sítios de Ligação , Western Blotting , Linhagem Celular , Núcleo Celular/metabolismo , Sistema Livre de Células , Chlorocebus aethiops , Colesterol/síntese química , Colesterol/química , Colesterol/farmacologia , Ácidos Cólicos/síntese química , Ácidos Cólicos/química , Ácidos Cólicos/farmacologia , Proteínas de Ligação a DNA , Transferência de Energia , Fluorescência , Histona Acetiltransferases , Hidroxicolesteróis/síntese química , Hidroxicolesteróis/química , Hidroxicolesteróis/farmacologia , Cetocolesteróis/síntese química , Cetocolesteróis/química , Cetocolesteróis/farmacologia , Receptores X do Fígado , Modelos Moleculares , Dados de Sequência Molecular , Coativador 1 de Receptor Nuclear , Receptores Nucleares Órfãos , Receptores Citoplasmáticos e Nucleares/antagonistas & inibidores , Receptores de Esteroides/antagonistas & inibidores , Estereoisomerismo , Esteróis/síntese química , Esteróis/química , Relação Estrutura-Atividade , Fatores de Transcrição/metabolismo , Triptofano/químicaRESUMO
The G12 subfamily of heterotrimeric G proteins, comprised of the alpha-subunits Galpha12 and Galpha13, has been implicated as a signaling component in cellular processes ranging from cytoskeletal changes to cell growth and oncogenesis. In an attempt to elucidate specific roles of this subfamily in cell regulation, we sought to identify molecular targets of Galpha12. Here we show a specific interaction between the G12 subfamily and the cytoplasmic tails of several members of the cadherin family of cell-surface adhesion proteins. Galpha12 or Galpha13 binding causes dissociation of the transcriptional activator beta-catenin from cadherins. Furthermore, in cells lacking the adenomatous polyposis coli protein required for beta-catenin degradation, expression of mutationally activated Galpha12 or Galpha13 causes an increase in beta-catenin-mediated transcriptional activation. These findings provide a potential molecular mechanism for the previously reported cellular transforming ability of the G12 subfamily and reveal a link between heterotrimeric G proteins and cellular processes controlling growth and differentiation.
Assuntos
Caderinas/metabolismo , Proteínas do Citoesqueleto/metabolismo , Proteínas Heterotriméricas de Ligação ao GTP/metabolismo , Transdução de Sinais/fisiologia , Transativadores , Adenocarcinoma/genética , Adenocarcinoma/patologia , Proteína da Polipose Adenomatosa do Colo , Caderinas/química , Adesão Celular , Linhagem Celular , Núcleo Celular/metabolismo , Neoplasias Colorretais/genética , Neoplasias Colorretais/patologia , Cisteína Endopeptidases/metabolismo , Citoplasma/metabolismo , Técnica Indireta de Fluorescência para Anticorpo , Subunidades alfa G12-G13 de Proteínas de Ligação ao GTP , Genes APC , Proteínas Heterotriméricas de Ligação ao GTP/genética , Humanos , Rim , Complexos Multienzimáticos/metabolismo , Complexo de Endopeptidases do Proteassoma , Ligação Proteica , Estrutura Terciária de Proteína , Transporte Proteico , Proteínas Recombinantes de Fusão/metabolismo , Saccharomyces cerevisiae/genética , Transcrição Gênica , Células Tumorais Cultivadas , Ubiquitinas/metabolismo , beta CateninaRESUMO
BACKGROUND: Angiogenesis, the formation of new vessels from the existing vasculature, is a critical process during early development as well as in a number of disease processes. Tie2 (also known as Tek) is an endothelium-specific receptor tyrosine kinase involved in both angiogenesis and vasculature maintenance. RESULTS: We have determined the crystal structure of the Tie2 kinase domain to 2.2 A resolution. The structure contains the catalytic core, the kinase insert domain (KID), and the C-terminal tail. The overall fold is similar to that observed in other serine/threonine and tyrosine kinase structures; however, several unique features distinguish the Tie2 structure from those of other kinases. The Tie2 nucleotide binding loop is in an inhibitory conformation, which is not seen in other kinase structures, while its activation loop adopts an "activated-like" conformation in the absence of phosphorylation. Tyr-897, located in the N-terminal domain, may negatively regulate the activity of Tie2 by preventing dimerization of the kinase domains or by recruiting phosphatases when it is phosphorylated. CONCLUSION: Regulation of the kinase activity of Tie2 is a complex process. Conformational changes in the nucleotide binding loop, activation loop, C helix, and the C-terminal tail are required for ATP and substrate binding.
Assuntos
Receptores Proteína Tirosina Quinases/química , Substituição de Aminoácidos , Vasos Sanguíneos/anormalidades , Domínio Catalítico , Cristalografia por Raios X , Dimerização , Genes Dominantes , Humanos , Ligação de Hidrogênio , Espectrometria de Massas , Modelos Moleculares , Mutagênese Sítio-Dirigida , Fosforilação , Ligação Proteica , Conformação Proteica , Dobramento de Proteína , Processamento de Proteína Pós-Traducional , Estrutura Terciária de Proteína , Receptores Proteína Tirosina Quinases/antagonistas & inibidores , Receptores Proteína Tirosina Quinases/genética , Receptores Proteína Tirosina Quinases/metabolismo , Receptor TIE-2 , Proteínas Recombinantes de Fusão/química , Relação Estrutura-Atividade , Domínios de Homologia de srcRESUMO
Bile acids repress the transcription of cytochrome P450 7A1 (CYP7A1), which catalyzes the rate-limiting step in bile acid biosynthesis. Although bile acids activate the farnesoid X receptor (FXR), the mechanism underlying bile acid-mediated repression of CYP7A1 remained unclear. We have used a potent, nonsteroidal FXR ligand to show that FXR induces expression of small heterodimer partner 1 (SHP-1), an atypical member of the nuclear receptor family that lacks a DNA-binding domain. SHP-1 represses expression of CYP7A1 by inhibiting the activity of liver receptor homolog 1 (LRH-1), an orphan nuclear receptor that is known to regulate CYP7A1 expression positively. This bile acid-activated regulatory cascade provides a molecular basis for the coordinate suppression of CYP7A1 and other genes involved in bile acid biosynthesis.
Assuntos
Ácidos e Sais Biliares/biossíntese , Proteínas de Ligação a DNA/metabolismo , Proteínas Tirosina Fosfatases/metabolismo , Receptores Citoplasmáticos e Nucleares/metabolismo , Fatores de Transcrição/metabolismo , Animais , Northern Blotting , Células Cultivadas , Colesterol 7-alfa-Hidroxilase/genética , Colesterol 7-alfa-Hidroxilase/metabolismo , Proteínas de Ligação a DNA/genética , Regulação Enzimológica da Expressão Gênica/fisiologia , Hepatócitos/citologia , Hepatócitos/enzimologia , Humanos , Peptídeos e Proteínas de Sinalização Intracelular , Masculino , Regiões Promotoras Genéticas/fisiologia , Proteína Tirosina Fosfatase não Receptora Tipo 11 , Proteína Tirosina Fosfatase não Receptora Tipo 6 , Proteínas Tirosina Fosfatases/genética , RNA Mensageiro/análise , Ratos , Ratos Endogâmicos F344 , Receptores Citoplasmáticos e Nucleares/genética , Proteínas Repressoras/genética , Proteínas Repressoras/metabolismo , Fatores de Transcrição/genética , TransfecçãoRESUMO
Transcription of genes encoding cytochrome P450 3A (CYP3A) monooxygenases is induced by a variety of xenobiotics and natural steroids. There are marked differences in the compounds that induce CYP3A gene expression between species. Recently, the mouse and human pregnane X receptor (PXR) were shown to be activated by compounds that induce CYP3A expression. However, most studies of CYP3A regulation have been performed using rabbit and rat hepatocytes. Here, we report the cloning and characterization of PXR from these two species. PXR is remarkably divergent between species, with the rabbit, rat, and human receptors sharing only approximately 80% amino acid identity in their ligand-binding domains. This sequence divergence is reflected by marked pharmacological differences in PXR activation profiles. For example, the macrolide antibiotic rifampicin, the antidiabetic drug troglitazone, and the hypocholesterolemic drug SR12813 are efficacious activators of the human and rabbit PXR but have little activity on the rat and mouse PXR. Conversely, pregnane 16alpha-carbonitrile is a more potent activator of the rat and mouse PXR than the human and rabbit receptor. The activities of xenobiotics in PXR activation assays correlate well with their ability to induce CYP3A expression in primary hepatocytes. Through the use of a novel scintillation proximity binding assay, we demonstrate that many of the compounds that induce CYP3A expression bind directly to human PXR. These data establish PXR as a promiscuous xenobiotic receptor that has diverged during evolution.
Assuntos
Hidrocarboneto de Aril Hidroxilases , Receptores Citoplasmáticos e Nucleares/química , Receptores de Esteroides/química , Xenobióticos/metabolismo , Sequência de Aminoácidos , Animais , Anticolesterolemiantes/farmacologia , Northern Blotting , Clonagem Molecular , Citocromo P-450 CYP3A , Sistema Enzimático do Citocromo P-450/metabolismo , Difosfonatos/farmacologia , Relação Dose-Resposta a Droga , Evolução Molecular , Humanos , Ligantes , Fígado/metabolismo , Camundongos , Dados de Sequência Molecular , Oxirredutases N-Desmetilantes/metabolismo , Receptor de Pregnano X , Ligação Proteica , Coelhos , Ratos , Receptores Citoplasmáticos e Nucleares/genética , Receptores Citoplasmáticos e Nucleares/metabolismo , Receptores de Esteroides/genética , Receptores de Esteroides/metabolismo , Proteínas Recombinantes/metabolismo , Homologia de Sequência de Aminoácidos , TransfecçãoRESUMO
An important step in differentiating the unique physiological roles of the alpha and beta forms of estrogen receptor is to determine the precise expression pattern of each of these receptors. We report the generation and characterization of a murine IgG1 monoclonal antibody (MAb), ER15.64A that is ERbeta subtype-specific and capable of recognizing full-length human ERbeta as well as all of its known protein isoforms. ER15.64A, raised against a ERbeta peptide (aa2-18)-keyhole limpet hemocyanine conjugate, reacted to the immunizing peptide and the full-length E. coli expressed ERbeta in ELISA and BIAcore assays. It also immunostained nuclei of Sf9 insect cells that were infected with an ERbeta-baculovirus. In Western analysis, ER15.64A recognized ERbeta1 and ERbeta2 proteins from a reticulocyte in vitro transcription/translation preparation. This antibody did not cross-react with recombinant ERalpha in ELISA, BIAcore, immunocytochemistry, or Western blot analysis. The specificity of ER15.64A should make this antibody a useful tool for monitoring expression of ERbeta and its isoforms at the protein level and should aid in distinguishing the pattern of ERbeta receptor expression from that of ERalpha.
Assuntos
Anticorpos Monoclonais/biossíntese , Receptores de Estrogênio/imunologia , Animais , Anticorpos Monoclonais/imunologia , Anticorpos Monoclonais/isolamento & purificação , Especificidade de Anticorpos , Reações Cruzadas , Receptor beta de Estrogênio , Feminino , Humanos , Hibridomas , Imunoglobulina G/biossíntese , Imunoglobulina G/imunologia , Imunoglobulina G/isolamento & purificação , Imuno-Histoquímica , Camundongos , Isoformas de Proteínas/imunologia , Receptores de Estrogênio/metabolismo , Transdução Genética , Células Tumorais CultivadasRESUMO
It has been shown in previous studies that a variety of estrogen receptor (ER) beta mRNA transcripts are expressed in human breast cancer cell lines and tumors. To complement the RNA expression studies, we have developed ER-beta-specific antibodies to characterize ER-beta protein expression in breast cancer cell lines and tumors. Monoclonal antibodies were made against a peptide representing the first 18 amino acids of the longest ER-beta open reading frame reported to date, and polyclonal antibodies were made against a peptide within the ER-beta B domain. By Western blot analysis, we show that ER-beta protein is expressed in all cancer cell lines tested and in three of five breast tumor samples. The breast cancer cell lines showed variation in the size of the expressed ER-beta protein. The longest form detected was consistent with the 530-amino acid, full-length ER-beta sequence. Shorter ER-beta isoforms were detected in the ER-alpha-negative MDA-MB-231 and MDA-MB-435 breast cancer cell lines, likely corresponding to previously described COOH-terminal RNA variant isoforms.
Assuntos
Neoplasias da Mama/genética , Neoplasias da Mama/metabolismo , Receptores de Estrogênio/genética , Receptores de Estrogênio/metabolismo , Western Blotting , DNA Complementar/análise , Receptor beta de Estrogênio , Regulação Neoplásica da Expressão Gênica , Humanos , Osteossarcoma/metabolismo , Fenótipo , Isoformas de Proteínas , RNA Mensageiro/metabolismo , Células Tumorais CultivadasRESUMO
The cytochrome P-450 monooxygenase 3A4 (CYP3A4) is responsible for the oxidative metabolism of a wide variety of xenobiotics including an estimated 60% of all clinically used drugs. Although expression of the CYP3A4 gene is known to be induced in response to a variety of compounds, the mechanism underlying this induction, which represents a basis for drug interactions in patients, has remained unclear. We report the identification of a human (h) orphan nuclear receptor, termed the pregnane X receptor (PXR), that binds to a response element in the CYP3A4 promoter and is activated by a range of drugs known to induce CYP3A4 expression. Comparison of hPXR with the recently cloned mouse PXR reveals marked differences in their activation by certain drugs, which may account in part for the species-specific effects of compounds on CYP3A gene expression. These findings provide a molecular explanation for the ability of disparate chemicals to induce CYP3A4 levels and, furthermore, provide a basis for developing in vitro assays to aid in predicting whether drugs will interact in humans.
Assuntos
Sistema Enzimático do Citocromo P-450/metabolismo , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Oxigenases de Função Mista/metabolismo , Preparações Farmacêuticas/metabolismo , Receptores Citoplasmáticos e Nucleares/química , Receptores de Esteroides/química , Sequência de Aminoácidos , Sequência de Bases , Linhagem Celular , Clonagem Molecular , Citocromo P-450 CYP3A , Proteínas de Ligação a DNA/análise , Ativação Enzimática/efeitos dos fármacos , Indução Enzimática/fisiologia , Genes Reporter/genética , Histona Acetiltransferases , Humanos , Dados de Sequência Molecular , Estrutura Molecular , Coativador 1 de Receptor Nuclear , Receptor de Pregnano X , Regiões Promotoras Genéticas/genética , RNA Mensageiro/metabolismo , Análise de Sequência de DNA , Homologia de Sequência de Aminoácidos , Fatores de Transcrição/metabolismo , Transfecção/genéticaRESUMO
Multiple transcripts which arise from the human estrogen receptor beta (ER beta) gene have been characterized. Three full length isoforms of the hER beta gene, designated hER beta 1-3, were identified in a testis cDNA library. An additional two isoforms, designated hER beta 4 and hER beta 5, were identified by PCR amplification from testis cDNA and from the MDA-MB 435 cell line. hER beta 1 corresponds to the previously described hER beta. All five isoforms diverge at a common position within the predicted helix 10 of the ligand binding domain of hER beta, with nucleotide sequences consistent with differential exon usage. The hER beta isoform mRNAs displayed a differential pattern of expression in human tissues and in tumor cell lines when analyzed by RT-PCR. Further characterization of the three full length isoforms, hER beta 1-3, by in vitro band shift studies indicated that the isoforms were able to form DNA-binding homodimers and heterodimers with each other and with the ER alpha subtype.
Assuntos
Receptores de Estrogênio/química , Receptores de Estrogênio/genética , Processamento Alternativo , Sequência de Aminoácidos , Sequência de Bases , Clonagem Molecular , Proteínas de Ligação a DNA/metabolismo , Dimerização , Receptor beta de Estrogênio , Estrogênios/genética , Expressão Gênica , Humanos , Isomerismo , Masculino , Dados de Sequência Molecular , Especificidade de Órgãos/genética , RNA Mensageiro/biossíntese , Receptores de Estrogênio/biossíntese , Sequências Reguladoras de Ácido Nucleico , TestículoRESUMO
Steroid hormones exert profound effects on differentiation, development, and homeostasis in higher eukaryotes through interactions with nuclear receptors. We describe a novel orphan nuclear receptor, termed the pregnane X receptor (PXR), that is activated by naturally occurring steroids such as pregnenolone and progesterone, and synthetic glucocorticoids and antiglucocorticoids. PXR exists as two isoforms, PXR.1 and PXR.2, that are differentially activated by steroids. Notably, PXR.1 is efficaciously activated by pregnenolone 16alpha-carbonitrile, a glucocorticoid receptor antagonist that induces the expression of the CYP3A family of steroid hydroxylases and modulates sterol and bile acid biosynthesis in vivo. Our results provide evidence for the existence of a novel steroid hormone signaling pathway with potential implications in the regulation of steroid hormone and sterol homeostasis.
Assuntos
Hidrocarboneto de Aril Hidroxilases , Pregnanos/farmacologia , Receptores Citoplasmáticos e Nucleares/efeitos dos fármacos , Receptores Citoplasmáticos e Nucleares/genética , Receptores de Esteroides/genética , Esteroides/fisiologia , Sequência de Aminoácidos , Animais , Sequência de Bases , Clonagem Molecular , Sequência Conservada/genética , Sequência Conservada/fisiologia , Citocromo P-450 CYP3A , Sistema Enzimático do Citocromo P-450/genética , Embrião de Mamíferos/química , Embrião de Mamíferos/metabolismo , Expressão Gênica/genética , Expressão Gênica/fisiologia , Genes/genética , Glucocorticoides/síntese química , Glucocorticoides/metabolismo , Glucocorticoides/farmacologia , Histona Acetiltransferases , Camundongos , Dados de Sequência Molecular , Coativador 1 de Receptor Nuclear , Oxirredutases N-Desmetilantes/genética , Receptor de Pregnano X , Pregnanos/síntese química , Pregnanos/metabolismo , Regiões Promotoras Genéticas/genética , Regiões Promotoras Genéticas/fisiologia , Ligação Proteica , Receptores Citoplasmáticos e Nucleares/fisiologia , Transdução de Sinais , Fatores de Transcrição/metabolismoRESUMO
The objective of this study was to determine if the ingestion of snow contaminated with Chlamydomonas nivalis causes diarrhea. The design was a single-blind crossover. Subjects were seven healthy volunteers, aged 24-56 who ingested 500 g of snow contaminated with C. nivalis. Outcome was measured by stool and diarrhea frequency. No differences in stool or diarrhea frequency were noted between treatment and placebo groups. The conclusion is that in this pilot study, there was no evidence supporting the concern that ingestion of "red snow" causes diarrhea.
Assuntos
Chlamydomonas , Diarreia/etiologia , Parasitologia de Alimentos , Neve , Adulto , Animais , Estudos Cross-Over , Diarreia/parasitologia , Humanos , Pessoa de Meia-Idade , Montanhismo , Projetos Piloto , Método Simples-CegoRESUMO
Human thymidylate synthase is a polymeric protein composed of two subunits with identical primary structures. In this study we determined the binding affinities of 5,10-methylene tetrahydropteroyltetraglutamate (folate substrate) and a group of close structural folate analog inhibitors. Thymidylate synthase bound both mono and polyglutamylated folate substrates and analogs more tightly in the presence of deoxyuridylate. These results and product inhibition studies confirmed that the orders of substrate addition and product release from thymidylate synthase were similar for mono and polyglutamylated substrates. Equilibrium dialysis studies showed that the folate substrate in a ternary complex with deoxyuridylate bound to one of the subunits (site A) with a Kd of 720 nM. The binding of the substrate to the second subunit (site B) was much weaker, and the Kd could not be determined by this method. However, dissociation constants for each subunit could be measured for the folate analog inhibitors, and, depending on the inhibitor, the relative Kd value for each subunit varied substantially. For example, formyl-5,8-dideazafolate and tetraglutamylated 10-propargyl-5,8-dideazafolate bound to both sites with similar Kd values, whereas D1694Glu4 bound to subunit A with a higher affinity (Kd = 1.0 nM) than to subunit B (Kd = 30 nM). In contrast, 1843U89 (mono or diglutamylated form) had a much higher affinity for subunit B (Kd approximately 0.1 nM) compared with subunit A (Kd approximately 400 nM). Enzyme inhibition kinetic analyses showed that the Ki values of 1843U89 were quite low (0.1 nM) and that the inhibition was noncompetitive. In contrast, the other folate analogs inhibited the enzyme via mixed inhibition (i.e. both the Km for the folate substrate and the Vmax were altered). We conclude that the two subunits of thymidylate synthase bind folate substrates and analogs differently and that the asymmetric binding of the ligands is the major factor that determines the inhibition kinetics of each folate analog inhibitor.
Assuntos
Ácido Fólico/análogos & derivados , Ácido Fólico/metabolismo , Timidilato Sintase/metabolismo , Sítios de Ligação , Radioisótopos de Carbono , Nucleotídeos de Desoxiuracil/metabolismo , Antagonistas do Ácido Fólico/metabolismo , Humanos , Indóis/metabolismo , Isoindóis , Cinética , Substâncias Macromoleculares , Matemática , Ligação Proteica , Quinazolinas/metabolismo , Relação Estrutura-Atividade , Timidilato Sintase/antagonistas & inibidoresRESUMO
Collagenous colitis should be added to the differential diagnosis of chronic, watery, nonbloody diarrhea with normal endoscopic findings. Patients with collagenous colitis are often middle-aged women previously diagnosed as having irritable bowel syndrome. The diagnosis of collagenous colitis is based on histologic evaluation of a rectal biopsy specimen. Biopsy shows a thickened, subepithelial, acellular, eosinophilic collagen band. Symptoms often resolve after treatment with oral sulfasalazine.
Assuntos
Colite/complicações , Colite/diagnóstico , Doenças do Colágeno/diagnóstico , Diarreia/etiologia , Fatores Etários , Sulfato de Bário , Biópsia , Doença Crônica , Colite/tratamento farmacológico , Colite/epidemiologia , Colite/patologia , Doenças do Colágeno/complicações , Doenças do Colágeno/tratamento farmacológico , Doenças do Colágeno/epidemiologia , Diagnóstico Diferencial , Enema , Feminino , Humanos , Pessoa de Meia-Idade , Fatores Sexuais , Sigmoidoscopia , Sulfassalazina/administração & dosagem , Sulfassalazina/uso terapêuticoRESUMO
Spirituality is an important aspect of health care that is not often addressed in modern day primary medical practice. Controversy surrounds the role of spiritual issues in medical practice. Some of this stems from confusing spirituality with religion. This paper distinguishes between spiritual and religious issues and reviews the history of these issues in medicine, the growing medical literature in this area, and some practical guidelines for the practicing physician. The authors conclude that, when appropriate, spiritual issues should be addressed in patient care since they may have a positive impact on patient health and behavior, and recommend that the medical model be expanded to a biopsychosocial-spiritual one. The guidelines developed by the American Psychiatric Association provide a useful model for the practicing physician to follow. More research is needed in this area, but the authors conclude that enough is already known to support the inclusion of spiritual issues in medical education.
Assuntos
Saúde Holística , Relações Médico-Paciente , Atenção Primária à Saúde/normas , Religião e Medicina , Humanos , Cura Mental , Modelos Teóricos , Assistência Religiosa , Médicos de Família , Prática Profissional , Estados UnidosRESUMO
The effects of variation of aromatic ring size, shape, and side-chain position on antitumor activity and DNA binding in a series of carbocyclic 2-[(arylmethyl)amino]-2-methyl-1,3-propanediols (AMAPs) were examined. In general, the interaction of AMAPs with DNA increases as the intercalating ring system grows in area, with three distinct binding levels evident. Isomers from a specific ring system appear to bind DNA similarly. DNA binding is not the sole criterion for antitumor activity for the AMAPs studied; the magnitude of the delta Tm does not correlate with the antitumor activity observed. Significant in vivo P388 activity was seen for AMAP congeners from several tetracyclic ring systems. However, isomers from each of the specific ring systems produced a wide range of in vivo P388 activity. Thus, AMAP antitumor activity is not a function of the ring system per se, but rather appears to be related to the shape of the specific molecule. Three AMAP congeners (crisnatol (770U82, 773U82, and 502U83) are currently in clinical trials.
Assuntos
Antineoplásicos/síntese química , DNA/metabolismo , Substâncias Intercalantes/síntese química , Propilenoglicóis/síntese química , Animais , Antineoplásicos/uso terapêutico , Fenômenos Químicos , Química , Crisenos/síntese química , Crisenos/uso terapêutico , Substâncias Intercalantes/uso terapêutico , Leucemia P388/tratamento farmacológico , Camundongos , Propilenoglicóis/uso terapêutico , Relação Estrutura-AtividadeRESUMO
In the series of 1-pyrenylmethylamines studied in this work the relationships among structure, interaction with DNA, and murine antitumor activity were examined. Binding studies show that all of these 1-pyrenylmethylamine derivatives bind to some extent to DNA by intercalation. The presence of additional basic amine groups in the side chain enhances DNA binding due to electrostatic interactions. Those compounds containing only a single basic benzylic amine bind similarly to DNA. Only the presence of bulky side chains appears to decrease the DNA interactions in the compounds examined. Although antitumor activity is seen for (1-pyrenylmethyl)amino alcohols, useful antitumor activity in the series is limited to those congeners bearing the 2-amino-1,3-propanediol-type side chain. These derivatives bind moderately to DNA. DNA binding is a necessary but not sufficient criterion for antitumor activity in the series. In addition, the strength of DNA binding does not correlate with the antitumor activity in the group of active compounds. Three related 2-[(arylmethyl)amino]-1,3-propanediol derivatives (AMAPs) [crisnatol (770U82), 773U82, and 502U83] are currently in clinical trials as potential antitumor agents.